The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The peptide therapeutics market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of almost 9%, as per The Business Research Company’s market report!

Read More On The Peptide Therapeutics Market Report 2022 – https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

The Peptide Therapeutics Market Size In 2022 And Forecast

The global peptide therapeutics market is expected to grow from $34.12 billion in 2021 to $37.13 billion in 2022 at a compound annual growth rate (CAGR) of 8.8%. The global peptide therapeutics market size is expected to reach $52.19 billion in 2026 at a CAGR of 8.9%.

The peptide therapeutics market consists of sales of peptide therapeutics solutions by entities (organizations, sole traders, and partnerships) that refers to a special type of pharmaceutical drug made up of a string of carefully arranged amino acids.

Request for A Sample Of The Global Peptide Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

An Increase In The Prevalence Of Chronic Diseases Is Driving The Growth Of The Peptide Therapeutics Market

For instance, in 2020, according to the American Hospital Association (AHA), the national organization that represents and serves all types of hospitals and health care networks and their patients and communities, 157 million Americans were affected by chronic diseases in 2020, and it is estimated to reach 171 million by 2030. Therefore, the increase in the prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.

Competitive Landscape And The Regional Analysis Of The Peptide Therapeutics Market

Major players in the peptide therapeutics market are Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Sanofi, AstraZeneca plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Bachem Holding AG, Takeda Pharmaceutical Company Limited, Galena Biopharmaceuticals, Arch Biopartners, Arch Biopartners Inc., Novo Nordisk A/S, Circle Pharma Inc., and Corden Pharma GmbH.

Additionally, as per TBRC’s research – North America was the largest region in the peptide therapeutics market in 2021 holding the largest market share and Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The Peptide Therapeutics Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the peptide therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the peptide therapeutics market.

Technological Advancement – A Key Trend In The Peptide Therapeutics Market

The companies operating in peptide therapeutics are utilizing advanced technologies such as artificial intelligence to attain higher efficiency in drug development.

Peptide Therapeutics Market Segmentation By The Business Research Company

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Here Are Some Reports Related To The Peptide Therapeutics Market –

Leukemia Therapeutics Global Market Report 2022

Medical Foods Global Market Report 2022

Pharmaceutical Drug Delivery Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: